Stocktoria

Dogwood Therapeutics, Inc. DWTX

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2020-12-17

Dogwood Therapeutics, Inc. statistics & valuation

Market cap$55.5M
P / B0.7×
Return on equity-45.7%
Return on capital-32.1%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
202020212022202320242025
Operating margin (%)
202020212022202320242025
Return on equity (%)
-34.60% -110.10% -167.20% -139.10% -45.70% 202020212022202320242025
Shares outstanding
8.3M 8.3M 18.3M 770317 1.3M 29.7M 202020212022202320242025
Net debt ($)
202020212022202320242025
Share buybacks ($)
202020212022202320242025
Return on assets (%)
-32.90% -101.20% -146.30% -127.10% -13.10% -38.00% 202020212022202320242025
Free cash flow margin (%)
202020212022202320242025
Debt / equity (×)
202020212022202320242025
EPS ($)
-$2.10 -$1.92 -$1.11 -$7.05 -$12.52 -$7.13 202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020
Return on assets-38.0%-13.1%-127.1%-146.3%-101.2%-32.9%
Return on equity-45.7%122.0%-139.1%-167.2%-110.1%-34.6%
Current ratio2.765.2111.628.0212.3720.55

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.